Co-administration of AA98 with vorinostat attenuates Akt phosphorylation And downregulates 4E-BP1 expression, enhancing the sensitivity of ovarian cancer cells to vorinostat-induced apoptosis. This evidence concerns the gene AKT1 and ovarian carcinoma.